Zobrazeno 1 - 10
of 154
pro vyhledávání: '"Enaka A"'
Autor:
Commey, Kindness Lomotey1,2 (AUTHOR) kindnesslomotey@ph.sojo-u.ac.jp, Enaka, Airi1 (AUTHOR) mmhat.enk831@gmail.com, Nakamura, Ryota1 (AUTHOR) g1951079@m.sojo-u.ac.jp, Yamamoto, Asami1 (AUTHOR) g2051122@m.sojo-u.ac.jp, Tsukigawa, Kenji1,2 (AUTHOR) tsukigawa@ph.sojo-u.ac.jp, Nishi, Koji1,2 (AUTHOR) knishi@ph.sojo-u.ac.jp, Otagiri, Masaki1,2 (AUTHOR) otagirim@ph.sojo-u.ac.jp, Yamasaki, Keishi1,2 (AUTHOR) kcyama@ph.sojo-u.ac.jp
Publikováno v:
Toxins. Jul2024, Vol. 16 Issue 7, p316. 17p.
Autor:
Kindness Lomotey Commey, Airi Enaka, Ryota Nakamura, Asami Yamamoto, Kenji Tsukigawa, Koji Nishi, Masaki Otagiri, Keishi Yamasaki
Publikováno v:
Toxins, Vol 16, Iss 7, p 316 (2024)
The characteristic accumulation of circulating uremic toxins, such as indoxyl sulfate (IS), in chronic kidney disease (CKD) further exacerbates the disease progression. The gut microbiota, particularly gut bacterial-specific enzymes, represents a sel
Externí odkaz:
https://doaj.org/article/b847bccec066409f99b9381cd3db9e67
Autor:
Commey, Kindness L.1,2 (AUTHOR) g1971d03@m.sojo-u.ac.jp, Enaka, Airi1 (AUTHOR) g1851033@m.sojo-u.ac.jp, Nakamura, Ryota1 (AUTHOR) g1951079@m.sojo-u.ac.jp, Yamamoto, Asami1 (AUTHOR) g2051122@m.sojo-u.ac.jp, Tsukigawa, Kenji1,2 (AUTHOR) tsukigawa@ph.sojo-u.ac.jp, Nishi, Koji1,2 (AUTHOR) knishi@ph.sojo-u.ac.jp, Iohara, Daisuke1,2 (AUTHOR) dio@ph.sojo-u.ac.jp, Hirayama, Fumitoshi1,2 (AUTHOR) fhira@ph.sojo-u.ac.jp, Otagiri, Masaki1,2 (AUTHOR) otagirim@ph.sojo-u.ac.jp, Yamasaki, Keishi1,2 (AUTHOR) otagirim@ph.sojo-u.ac.jp
Publikováno v:
Pharmaceutics. Jan2024, Vol. 16 Issue 1, p82. 15p.
Autor:
Kindness L. Commey, Airi Enaka, Ryota Nakamura, Asami Yamamoto, Kenji Tsukigawa, Koji Nishi, Daisuke Iohara, Fumitoshi Hirayama, Masaki Otagiri, Keishi Yamasaki
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 82 (2024)
Despite major improvements brought about by the introduction of taste-masked formulations of 4-phenylbutyrate (PB), poor compliance remains a significant drawback to treatment for some pediatric and dysphagic patients with urea cycle disorders (UCDs)
Externí odkaz:
https://doaj.org/article/339c5314131e47499ce83800b725a500
Autor:
Miki Hoshi, Nobuaki Kobayashi, Katsushi Tanaka, Kohei Somekawa, Ayami Kaneko, Ami Izawa, Kenichi Seki, Yoichi Tagami, Ayako Aoki, Hiroaki Fujii, Keisuke Watanabe, Nobuyuki Horita, Yu Hara, Mai Matsumura, Makiko Enaka, Maki Hagihara, Takeshi Kaneko
Publikováno v:
Thoracic Cancer, Vol 12, Iss 23, Pp 3281-3285 (2021)
Abstract Lung lesions of Hodgkin's lymphoma (HL) are rare and difficult to diagnose by nonsurgical biopsy. We herein present the case of a 72‐year‐old Japanese male who presented with accumulation of lung infiltrates and masses bilaterally on the
Externí odkaz:
https://doaj.org/article/6f81bcc3cafb4118927952b19b4fd5cc
Publikováno v:
In The American Journal of Pathology March 2021 191(3):555-566
Autor:
Shingo Kato, Kentaro Fushimi, Yuichiro Yabuki, Yoshiaki Maru, Sho Hasegawa, Tetsuya Matsuura, Daisuke Kurotaki, Akihiro Suzuki, Noritoshi Kobayashi, Masato Yoneda, Takuma Higurashi, Makiko Enaka, Tomohiko Tamura, Yoshitaka Hippo, Atsushi Nakajima
Publikováno v:
Oncogenesis, Vol 10, Iss 4, Pp 1-13 (2021)
Abstract Genetically engineered mice (GEM) are the gold standard for cancer modeling. However, strict recapitulation of stepwise carcinogenesis from a single tumor-initiating epithelial cell among genetically intact cells in adults is not feasible wi
Externí odkaz:
https://doaj.org/article/84bdc6ec5d514a57b1240fb80710cbb6
Autor:
Itaru Tojyo, Yukari Shintani, Takashi Nakanishi, Kenjiro Okamoto, Yukihiro Hiraishi, Shigeyuki Fujita, Mayu Enaka, Fuyuki Sato, Yasuteru Muragaki
Publikováno v:
Maxillofacial Plastic and Reconstructive Surgery, Vol 41, Iss 1, Pp 1-6 (2019)
Abstract Background Programmed cell death ligand 1 (PD-L1) is an immune checkpoint molecule that attenuates the immune response. PD-L1 contributes to failed antitumor immunity; thereby, blockade of PD-L1 with monoclonal antibody enhances the immune r
Externí odkaz:
https://doaj.org/article/aa2bb58369624aec9bb854c79ada1193
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hiroyoshi Kunimoto, Yumi Fukuchi, Koichi Murakami, Junji Ikeda, Hiroshi Teranaka, Ikuma Kato, Takuya Miyazaki, Makiko Enaka, Takayuki Mitsuhashi, Etsuko Yamazaki, Kaori Kameyama, Mitsuru Murata, Shinichiro Okamoto, Hideaki Nakajima
Publikováno v:
HemaSphere, Vol 4, Iss 5, p e469 (2020)
Abstract. Acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) with both inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and monosomy 7 defines an extremely aggressive myeloid cancer whose molecular pathogenesis and optimal therapeutic strategy still r
Externí odkaz:
https://doaj.org/article/92b2e246fb4b4dbd905e872de929759c